Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,892 total articles

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Can-Fite BioPharma reported positive results from its Phase 2a trial of Namodenoson in advanced pancreatic cancer patients. The study showed preliminary evidence of clinical activity with stable disease in over 30% of evaluable patients, including prolonged treatment of one patient beyond 16 months. Namodenoson demonstrated a favorable safety profi…

TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers

TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers

TOMI Environmental Solutions, listed on Nasdaq as TOMZ, has signed a non-binding letter of intent to merge with U.S.-based Carbonium Core, a producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure. This merger aims to diversify TOMI's business by adding a vertically integrated, domestically controlled …

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

FibroBiologics, a clinical-stage biotech company specializing in fibroblast-based therapies, announced it will present preclinical data from its CYPS317 program targeting psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting. The presentation showcases the company’s progress in developing novel treatments for chronic diseases u…

Critical Metals Corp. Closes Acquisition of Final 50.5% Interest in Tanbreez, Bringing Current Ownership to 92.5%

Critical Metals Corp. Closes Acquisition of Final 50.5% Interest in Tanbreez, Bringing Current Ownership to 92.5%

Critical Metals Corp. has closed the acquisition of an additional 50.5% interest in the Tanbreez Mining Greenland project, bringing its ownership to 92.5%. The company issued 14.5 million shares for the transaction and announced a non-binding letter of intent to acquire the remaining 7.5% from European Lithium Ltd. Tanbreez is one of the world's la…

Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026

Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026

Quoin Pharmaceuticals Ltd., a NASDAQ-listed specialty pharmaceutical company focusing on rare and orphan diseases, announced it will release its first quarter 2026 financial results and provide a corporate update on May 7, 2026, including operational and financial highlights as well as recent achievements related to its late clinical-stage pipeline…

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

Enlivex Ltd., a Nasdaq-listed longevity therapeutics company, announced that its digital treasury asset, the RAIN token, has been listed on HTX, a leading global cryptocurrency exchange. This listing expands the global accessibility and liquidity of the RAIN token, which underpins Enlivex's prediction markets treasury strategy. The company holds ap…

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

Microbot Medical Inc., a US-listed medical device company specializing in robotic endovascular procedures, announces the appointment of Alon Tamir as VP of Sales for Europe, Middle East, and Asia (EMEA). This strategic hire supports the company's planned expansion beyond the US following FDA clearance and a full market release of its LIBERTY Endova…

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

Pliant Therapeutics announced the dosing of the first patient in the FORTIFY Phase 1b clinical trial examining PLN-101095 combined with pembrolizumab in patients with immune checkpoint inhibitor (ICI)-refractory advanced or metastatic solid tumors. The trial targets three patient cohorts: non-small cell lung cancer (NSCLC), clear cell renal cell ca…

Alliance Entertainment to Host Third Quarter Fiscal Year 2026 Results Conference Call on May 14 at 4:30 p.m. Eastern Time

Alliance Entertainment to Host Third Quarter Fiscal Year 2026 Results Conference Call on May 14 at 4:30 p.m. Eastern Time

Alliance Entertainment Holding Corporation, a leading distributor and fulfillment partner in the entertainment and pop culture collectibles sector, has scheduled its third quarter fiscal year 2026 results conference call for May 14, 2026. Executives will discuss the company's financial performance ended March 31, 2026, followed by a Q&A session. Th…

InterDigital Announces Financial Results for First Quarter 2026

InterDigital Announces Financial Results for First Quarter 2026

InterDigital announced its financial results for Q1 2026, highlighting six new licensing agreements including a renewal with Xiaomi and a new license with LG Electronics. The company achieved record smartphone annualized recurring revenue (ARR) of $491.8 million, a 18% increase year-over-year, and surpassed the top end of its guidance for revenue, …

Eos Energy Enterprises Appoints Alessandro Lagi as Chief Financial Officer to Advance American Storage Infrastructure at Scale

Eos Energy Enterprises Appoints Alessandro Lagi as Chief Financial Officer to Advance American Storage Infrastructure at Scale

Eos Energy Enterprises, a US-based innovator in zinc-based battery energy storage systems, announced Alessandro Lagi as its new Chief Financial Officer. Lagi brings extensive global financial leadership experience from companies like Johnson Controls and Baker Hughes. His appointment aims to strengthen Eos's operational scaling and manufacturing ex…

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)

Cadrenal Therapeutics announced it completed an End-of-Phase 2 meeting with the FDA concerning its investigational drug CAD-1005 for treating heparin-induced thrombocytopenia (HIT). The FDA provided critical guidance on the Phase 3 trial design, enabling the company to proceed directly to a randomized, blinded, placebo-controlled pivotal trial, wit…

BOSS Money Makes it Easier to Honor Mom This Mother's Day

BOSS Money Makes it Easier to Honor Mom This Mother's Day

IDT Corporation's remittance service, BOSS Money, announced special Mother's Day promotions for new and existing customers during May 2026. These offers include fee discounts and zero-fee transfers to popular remittance destinations, aiming to enhance customer loyalty and increase transaction volume during a key seasonal period for international mo…

AVAX One Advances Alberta AI/HPC Powered Land Program; Confirms Behind-the-Meter Natural Gas Infrastructure Model and Expanded Site Pipeline

AVAX One Advances Alberta AI/HPC Powered Land Program; Confirms Behind-the-Meter Natural Gas Infrastructure Model and Expanded Site Pipeline

AVAX One Technology Ltd. announced significant progress on its 10 MW Tier 3-ready AI/HPC powered land site in Alberta, employing a behind-the-meter natural gas power generation model. The company partnered with BlueFlare Energy Solutions as infrastructure development partner and is expanding its site pipeline in Western Canada. AVAX One aims to del…

Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

Teva Pharmaceutical Industries Ltd. reported exceeding its 2025 sustainability-linked bond targets, including substantial reductions in greenhouse gas emissions, expansion of global access to medicines through product donations to nearly 8 million people, and significant healthcare savings from its generic medicines portfolio. The company continues…

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP TMS announces publication of the HIFI-2 study, the largest prospective trial demonstrating that its Focal One Robotic High-Intensity Focused Ultrasound (HIFU) provides effective, organ-preserving treatment for patients with localized prostate cancer recurrence following radiotherapy. The study highlights high androgen deprivation therapy-free …